|
1
|
He R, Lin H, Xie S, Lv Q, Kong Y, Li L, Xu H, Wang J, Li W, Fang P, Wu Y, Liu Z. Donor tolerability of convalescent plasma donation. J Clin Apher 2021; 36:429-436. [PMID: 33587767 PMCID: PMC8013347 DOI: 10.1002/jca.21882] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2020] [Revised: 01/18/2021] [Accepted: 01/22/2021] [Indexed: 11/06/2022]
Abstract
Background Since early 2020, convalescent plasma has been widely used for treating coronavirus disease 2019 (COVID‐19). There is limited information regarding donor tolerability of convalescent plasma donation. In this study, we evaluated the short‐term donor tolerability of convalescent plasma donation. Methods A prospective study of 309 convalescent plasma donation related adverse events were conducted at Wuhan Blood Center of China, from February 12 to April 1, 2020. Additionally, up to 28‐day post‐donation follow‐ups were performed on the donors. Results Sixteen (5.2%) adverse events were reported in 309 donations. All of these were mild vasovagal without loss of consciousness. The frequency of adverse reactions was higher in donors with a per donation volume of >8 mL/kg body weight or ≥ 600 mL, <100 mm Hg in pre‐donation systolic blood pressure, or less than 28 days from the onset of COVID‐19 symptoms. There was no correlation to donation history, weight, sex, ABO blood type, pre‐donation diastolic blood pressure, pulse, or hemoglobin. Conclusion The donation of convalescent plasma is generally safe. Mitigation of risk factors associated with adverse events can further enhance donor tolerability of convalescent plasma donation.
Collapse
Affiliation(s)
- Rui He
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| | - Hui Lin
- Blood Collection Center, Wuhan Blood Center, Wuhan, Hubei Province, P.R. China
| | - Songli Xie
- Blood Collection Center, Wuhan Blood Center, Wuhan, Hubei Province, P.R. China
| | - Qilu Lv
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| | - Yujie Kong
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| | - Ling Li
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| | - Haixia Xu
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| | - Jue Wang
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| | - Wenjuan Li
- School of Public Health, Anhui Medical University, Hefei, China
| | - Peng Fang
- School of Public Health, Anhui Medical University, Hefei, China
| | - Yanyun Wu
- Clinical Transfusion Center, University of Miami, Miami, Florida, USA
| | - Zhong Liu
- Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Chengdu, Sichuan Province, P.R. China.,Key laboratory of transfusion adverse reactions, CAMS, Chengdu, Sichuan Province, P.R. China
| |
Collapse
|
|
2
|
Pérez Giraldo B, Arroyo Marlés LP, Nonsoque Cholo MA, Sánchez Herrera B, Guevara Lozano M. Transformar la asistencia de necesidad básica en un momento de cuidado. INVESTIGACIÓN EN ENFERMERÍA: IMAGEN Y DESARROLLO 2021. [DOI: 10.11144/javeriana.ie22.tanb] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
Abstract
Introducción. Conocer y atender debidamente las necesidades de un ser humano en medio de su vulnerabilidad continúa siendo un reto vigente. Objetivo. Describir la transformación de la “Atención a las necesidades básicas” en un momento de cuidado de enfermería para favorecer la adaptación del paciente y su cuidador familiar durante la hospitalización, en la Clínica Universidad de La Sabana, para el periodo 2018-2019. Método. Esta es una investigación metodológica en enfermería, realizada bajo lineamientos del Modelo de Enfermería Universidad de La Sabana, que incluyó cuatro fases. Resultados. Es preciso que la atención a las necesidades básicas sea respaldada en la mejor evidencia disponible, y con un trato humanizado. Hacer visible este proceso permitió medirlo y mejorarlo. Conclusiones. Para brindar un cuidado humano y seguro, no basta la buena intención, es necesario garantizar dos condiciones; por un lado, el compromiso requerido para soportarlo con la mejor evidencia disponible, aumentando la calidad del cuidado y la calidez o tono humano; y, por otro, el respeto y reconocimiento de la dignidad de las personas, favoreciendo el vínculo con ellas y su autonomía, lo que a su vez repercute positivamente en el desarrollo de la enfermería.
Collapse
|